ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies | Science

A class of broadly reactive antibodies target a cryptic fusion peptide epitope exposed upon coronavirus spike protein binding to ACE2.